Last reviewed · How we verify

NCT06660953

Comparison of Analgesic Efficacy ESP Block and QLB II in Kidney Transplantation

Completed Phase 4 Last updated 28 October 2024
What this trial tests

Phase 4 trial testing Erector Spinae Plane Block in Postoperative Analgesia in 66 participants. Completed in 30 March 2023.

Timeline
30 September 2022
Primary endpoint
28 February 2023
30 March 2023

Quick facts

Lead sponsorUniversity of Gaziantep
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposesupportive care
Enrollment66
Start date30 September 2022
Primary completion28 February 2023
Estimated completion30 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

University of Gaziantep

Who can join

Adults 18 to 70, any sex, with Postoperative Analgesia or Intraoperative Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Renal transplantation is an increasingly common surgery in recent years. Opioid and/or NSAID use is common in postoperative pain management. However, these drugs have many side effects. Peripheral blocks provide more effective analgesia both intra and postoperatively, and also reduce the use of systemic drugs. The aim of this study was to compare the effects of two different nerve blocks (ESP vs QLB II) on intraoperative remifentanil dose and postoperative analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Erector Spinae Plane Block

Trials testing the same drug.

Other recruiting trials for Postoperative Analgesia

Currently open trials in the same condition.

Other University of Gaziantep trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06660953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing